Funds and ETFs Aurobindo Pharma

Equities

AUROPHARMA

INE406A01037

Pharmaceuticals

Market Closed - NSE India S.E. 07:40:29 2024-04-24 am EDT 5-day change 1st Jan Change
1,084 INR -0.84% Intraday chart for Aurobindo Pharma -2.73% +0.00%

ETFs positioned on Aurobindo Pharma

Name Weight AuM 1st Jan change Investor Rating
0.32% 6 M€ +6.07% -
0.22% 18 M€ +2.01%
0.12% 11 M€ +0.34%
0.09% 1 M€ +3.49% -
0.09% 3 M€ -.--% -
0.05% 441 M€ +3.08% -
0.05% 2,808 M€ +5.23% -
0.05% 149 M€ +0.56% -
0.03% 4 M€ -4.41% -
0.02% 117 M€ +0.83% -
0.01% 7 M€ +16.85% -
0.01% 31 M€ +3.19% -
0.01% 7 M€ +1.91% -
0.00% 34 M€ +2.14% -
0.00% 15 M€ +9.39%
0.00% 16 M€ -6.73%
0.00% 34 M€ +5.86% -
0.00% 389 M€ +6.68% -
0.00% 39 M€ +3.47% -
0.00% 302 M€ +4.23% -
0.00% 147 M€ +5.02% -
0.00% 17 M€ +1.23% -
0.00% 108 M€ +2.16% -
0.00% 52 M€ -0.52% -
0.00% 8 M€ -0.53% -
Aurobindo Pharma specializes in the research, development, manufacturing and marketing of active pharmaceutical ingredients and generic pharmaceuticals. The group's activity is organized around 2 product families : - generic drugs: for the treatment of neurological, cardiovascular, viral, gastroenterological, ophthalmologic and chronic diseases; - active pharmaceutical ingredients. At the end of March 2018, the group operated 23 production sites in India (19), the United States (3) and Brazil. Net sales are distributed geographically as follows: India (12%), the United States (46.5%), Europe (31.2%) and other (10.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
1,093 INR
Average target price
1,190 INR
Spread / Average Target
+8.90%
Consensus
  1. Stock Market
  2. Equities
  3. AUROPHARMA Stock
  4. Funds and ETFs Aurobindo Pharma